Cognizant Technology Solutions Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $21.4B+8.5% YoYTTM through 31 Mar 2026
Net Income $2.2B-0.5% YoYTTM through 31 Mar 2026
Free Cash Flow $2.5BTTM through 31 Mar 2026
Margins
| Current | |
|---|---|
| EBITDA Margin | 18.4% |
| Operating Margin | 15.8% |
| Net Margin | 10.4% |
Returns
14.8%ROE
10.9%ROA
15.8%ROIC
Balance Sheet Health
Debt / Equity0.04x
Current Ratio2.23x
Net Debt-$936Mnet cash position
Cash & Equivalents$1.5B
Quality Metrics
Altman Z-Score5.80
Piotroski F-Score8 / 9
FCF Margin11.5%
Rule of 4015.2
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $21.1B
Diluted EPS$4.61TTMFY2025: $4.56
Dividend
$0.66Per share, FY20261.12%Yield-7.2%5-yr growth
Capital Allocation
Capex Intensity1.3%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Health Sciences | $6.3B | +6.7% | |
| Financial Services | $6.2B | +7.4% | |
| Products and Resources | $5.3B | +10.5% | |
| Communications, Media and Technology | $3.3B | +1.0% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.